Actively Recruiting
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
Led by University of Minnesota · Updated on 2026-01-14
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the best length of time for postpartum remote blood pressure monitoring in patients who had hypertensive disorders during pregnancy. This study aims to find out how different program durations affect clinical outcomes in patients enrolled in a postpartum remote monitoring program at a single institution. There has been no prior evaluation to determine whether a 2-week or 6-week monitoring program is more beneficial. Participants are randomly assigned to one of two groups: a 2-week monitoring group or a 6-week monitoring group. Those in the 2-week group will stop the remote monitoring after 2 weeks and return to standard postpartum care, while those in the 6-week group will complete the full 6-week monitoring program. The program requires patients to submit blood pressure readings twice daily via a digital platform, which are reviewed by a dedicated nursing team who may adjust medications as needed. During the study, participants will be monitored for blood pressure outcomes at 6 weeks postpartum, including diastolic and systolic blood pressure, rates of severe hypertension, and new hypertension diagnoses. The study also tracks follow-up visit attendance, unscheduled medical visits, and patient satisfaction surveys. The total participation duration depends on the assigned program length, with clinical data collected to assess the impact of monitoring duration on health outcomes.
CONDITIONS
Brief Title
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Discharged after delivery at University of Minnesota Medical Center
- Enrolled into the HOPE-BP Program
You will not qualify if you...
- Ongoing antihypertensive medication use at 2 weeks (time of randomization)
- Have a medical comorbidity that would not be clinically appropriate to randomize
- Patients opted out of clinical research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - 2 to 6 weeks depending on randomization arm
Participants are remotely monitored for blood pressure postpartum by submitting readings twice daily. Those in the 2-week arm stop monitoring after 2 weeks, while those in the 6-week arm continue monitoring for 6 weeks total.
Daily blood pressure submissions with nursing review Monday to Friday
Duration - Up to 6 weeks postpartum
Participants' blood pressure outcomes and healthcare utilization are assessed at 6 weeks postpartum.
1 follow-up visit at 6 weeks postpartum
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
E
Erin Linden
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here